Richard A. Sandberg Sells 2,000 Shares of Precipio, Inc. (NASDAQ:PRPO) Stock

Precipio, Inc. (NASDAQ:PRPO) Director Richard A. Sandberg sold 2,000 shares of the firm’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $6.28, for a total transaction of $12,560.00. Following the transaction, the director now directly owns 16,525 shares in the company, valued at approximately $103,777. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Precipio Stock Performance

Shares of NASDAQ PRPO traded up $0.14 during mid-day trading on Tuesday, reaching $6.14. 2,708 shares of the company’s stock were exchanged, compared to its average volume of 7,398. The firm has a market capitalization of $9.10 million, a price-to-earnings ratio of -3.31 and a beta of 1.42. Precipio, Inc. has a 52 week low of $4.31 and a 52 week high of $8.49. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.73 and a quick ratio of 0.59. The firm has a 50-day moving average price of $6.48 and a two-hundred day moving average price of $5.89.

Precipio (NASDAQ:PRPO) last announced its earnings results on Tuesday, August 13th. The biotechnology company reported ($0.83) earnings per share (EPS) for the quarter. The business had revenue of $4.44 million for the quarter. Precipio had a negative net margin of 17.23% and a negative return on equity of 33.26%.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.